Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Azienda Ospedaliero-Universitaria di Parma
Mayo Clinic
University of Colorado, Denver
Cedars-Sinai Medical Center
Celgene
Shenzhen Second People's Hospital
Celldex Therapeutics
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Titan Pharmaceuticals
Case Comprehensive Cancer Center